Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.100
-0.050 (-1.59%)
At close: Apr 3, 2025, 4:00 PM
4.500
+1.400 (45.16%)
After-hours: Apr 3, 2025, 7:45 PM EDT

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-25.5-28.22-18.49-23.96-4
Upgrade
Depreciation & Amortization
0.170.160.150.110.12
Upgrade
Loss (Gain) From Sale of Assets
-0.0200.01-0.13
Upgrade
Stock-Based Compensation
3.221.411.433.430.23
Upgrade
Other Operating Activities
-1.10.550.995.971.53
Upgrade
Change in Accounts Receivable
-0.1-0.10.230.190.73
Upgrade
Change in Accounts Payable
-0.710.581.32-0.630.85
Upgrade
Change in Other Net Operating Assets
-5.954.88-0.040.070
Upgrade
Operating Cash Flow
-29.99-20.75-14.4-14.83-0.4
Upgrade
Capital Expenditures
-0.1-0.07-0.24-0.43-
Upgrade
Sale of Property, Plant & Equipment
0.03-0-0.08
Upgrade
Investment in Securities
--10.07-9-
Upgrade
Other Investing Activities
----5.02-0.06
Upgrade
Investing Cash Flow
-0.08-0.079.83-14.450.02
Upgrade
Short-Term Debt Issued
---0.10.71
Upgrade
Long-Term Debt Issued
---12.75-
Upgrade
Total Debt Issued
---12.850.71
Upgrade
Long-Term Debt Repaid
-9.14-0.08-0.14-0.59-1.1
Upgrade
Net Debt Issued (Repaid)
-9.14-0.08-0.1412.27-0.39
Upgrade
Issuance of Common Stock
54.9221.1610.9437.83-
Upgrade
Other Financing Activities
-----0.24
Upgrade
Financing Cash Flow
45.7821.0810.850.1-0.63
Upgrade
Foreign Exchange Rate Adjustments
-1.960.82-0.51-0.08-0
Upgrade
Net Cash Flow
13.761.085.7320.74-1.01
Upgrade
Free Cash Flow
-30.1-20.82-14.63-15.26-0.4
Upgrade
Free Cash Flow Per Share
-0.89-0.86-0.76-1.23-0.07
Upgrade
Cash Interest Paid
0.390.60.330.580.12
Upgrade
Levered Free Cash Flow
-20.95-10.78-8.72-16.43-0.75
Upgrade
Unlevered Free Cash Flow
-20.35-10.05-8.11-15.660.43
Upgrade
Change in Net Working Capital
6.76-5.86-1.567.57-1.49
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q